Open Access
| Numéro |
Med Sci (Paris)
Volume 36, Numéro 1, Janvier 2020
|
|
|---|---|---|
| Page(s) | 24 - 26 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2019256 | |
| Publié en ligne | 4 février 2020 | |
- Valle-Casuso JC Angin M Volant S et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab 2019 ; 29 : 611–626. [CrossRef] [PubMed] [Google Scholar]
- Roederer M Raju PA Mitra DK et al. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J Clin Invest 1997 ; 99 : 1555–1564. [CrossRef] [PubMed] [Google Scholar]
- Deeks SG Lewin SR Ross AL et al. International AIDS society: global scientific strategy towards an HIV cure. Nat Med 2012 ; 22 : 839–850. [Google Scholar]
- Heffern EF Ramani R Marshall G Kyei GB Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency. J Virus Erad 2019 ; 5 : 84–91. [PubMed] [Google Scholar]
- Zaikos TD Painter MM Sebastian Kettinger NT et al. Class 1-selective histone deacetylase (HDAC) inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression. J Virol 2018 ; 92 : 1–17. [Google Scholar]
- Xing Y Li A Yang Y et al. The regulation of FOXO1 and its role in disease progression. Life Sci 2018 ; 193 : 124–131. [CrossRef] [PubMed] [Google Scholar]
- Fabre S Lang V Harriague J et al. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol 2005 ; 174 : 4161–4171. [CrossRef] [PubMed] [Google Scholar]
- Nagashima T Shigematsu N Maruki R et al. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol 2010 ; 78 : 961–970. [CrossRef] [PubMed] [Google Scholar]
- Zou P Liu L Zheng L et al. Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 2014 ; 13 : 3759–3767. [PubMed] [Google Scholar]
- Tanaka H Nagashima T Shimaya A et al. Effects of the novel FoxO1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice. Eur J Pharmacol 2010 ; 645 : 185–191. [CrossRef] [PubMed] [Google Scholar]
- Tan P Guan H Xie L et al. FOXO1 inhibits osteoclastogenesis partially by antagonizing MYC. Sci Rep 2015 ; 5 : 16835. [CrossRef] [PubMed] [Google Scholar]
- Chung S Lee TJ Reader BF et al. FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype. Oncotarget 2016 ; 7 : 17532–17546. [PubMed] [Google Scholar]
- Descours B Cribier A Chable-Bessia C et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. Retrovirology 2012 ; 9 : 87. [CrossRef] [PubMed] [Google Scholar]
- Baldauf HM Pan X Erikson E et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 2012 ; 18 : 1682–1687. [CrossRef] [PubMed] [Google Scholar]
- Lahouassa H Daddacha W Hofmann H et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012 ; 13 : 223–228. [CrossRef] [PubMed] [Google Scholar]
- Roux A Leroy H De Muylder B et al. FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction. PLoS Pathog 2019 ; 15 : 1–23. [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.